- Home
- NMRA vs SKIN Comparison
NMRA vs SKIN Comparison
Compare NMRA & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- SKIN
- Stock Information
- Founded
- NMRA 2019
- SKIN 1997
- Country
- NMRA United States
- SKIN United States
- Employees
- NMRA N/A
- SKIN N/A
- Industry
- NMRA
- SKIN Package Goods/Cosmetics
- Sector
- NMRA
- SKIN Consumer Discretionary
- Exchange
- NMRA Nasdaq
- SKIN Nasdaq
- Market Cap
- NMRA 268.5M
- SKIN 295.5M
- IPO Year
- NMRA 2023
- SKIN N/A
- Fundamental
- Price
- NMRA $1.57
- SKIN $2.37
- Analyst Decision
- NMRA Hold
- SKIN Hold
- Analyst Count
- NMRA 8
- SKIN 1
- Target Price
- NMRA $5.83
- SKIN $1.25
- AVG Volume (30 Days)
- NMRA 376.3K
- SKIN 1.0M
- Earning Date
- NMRA 11-11-2025
- SKIN 11-11-2025
- Dividend Yield
- NMRA N/A
- SKIN N/A
- EPS Growth
- NMRA N/A
- SKIN N/A
- EPS
- NMRA N/A
- SKIN N/A
- Revenue
- NMRA N/A
- SKIN $310,064,000.00
- Revenue This Year
- NMRA N/A
- SKIN N/A
- Revenue Next Year
- NMRA N/A
- SKIN $6.05
- P/E Ratio
- NMRA N/A
- SKIN N/A
- Revenue Growth
- NMRA N/A
- SKIN N/A
- 52 Week Low
- NMRA $0.61
- SKIN $0.78
- 52 Week High
- NMRA $17.19
- SKIN $2.69
- Technical
- Relative Strength Index (RSI)
- NMRA 46.94
- SKIN 56.81
- Support Level
- NMRA $1.42
- SKIN $2.33
- Resistance Level
- NMRA $1.59
- SKIN $2.69
- Average True Range (ATR)
- NMRA 0.10
- SKIN 0.18
- MACD
- NMRA -0.03
- SKIN 0.01
- Stochastic Oscillator
- NMRA 36.14
- SKIN 57.33
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.